COMMUNIQUÉS West-GlobeNewswire

Active Biotech's rights issue over subscribed
16/04/2018
2018-04-16 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, JAPAN OR CANADA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OF THIS PRESS RELEASE WOULD [...]
Share buy-back week 15/2018
16/04/2018
Announcement 16 April 2018 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 3/2018 Coloplast has initiated the first part of the share buy-back programme totalling up [...]
PotNetwork Holdings, Inc. Purchases State of the Art Cryptocurrency Mining Facility
16/04/2018
With 115 Dedicated Cryptocurrency Mining Rigs, The Company Will Diversify By Establishing Itself In The Bitcoin Mining Industry FT LAUDERDALE, Fla., April 16, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--PotNetwork [...]
Gala Pharmaceutical to Launch Its First State-Of-The-Art Cannabis Testing Laboratories
16/04/2018
IRVINE, Calif., April 16, 2018 (GLOBE NEWSWIRE) -- Gala Pharmaceutical, Inc. (OTCBB: GLPH ), an emerging cannabis cloning and breeding company, today announced that it expects to build its first state-of-the-art testing [...]
G1 Therapeutics Announces Initiation of Phase 1b/2 Clinical Trial of G1T38 in Combination with Tagrisso for EGFR-Mutant Non-Small Cell Lung Cancer
16/04/2018
RESEARCH TRIANGLE PARK, N.C., April 16, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a clinical-stage oncology company, today announced that it has initiated a Phase 1b/2 clinical trial assessing [...]
Transactions under Novozymes’ stock buyback program
16/04/2018
Please read the full announcement in the attached PDF 2018_14_Stock_Buybackprogram_EN Attachment 2018_14_Stock_Buybackprogram_EN
Taiho Pharmaceutical and Helsinn Group present preclinical data at AACR Annual Meeting for a RET inhibitor under co-development as an attractive compound for anticancer therapy
16/04/2018
Taiho Pharma ceutical and Helsinn Group present preclinical data at AACR Annual Meeting for a RET inhibitor under co-development as an attractive compound for anticancer therapy Lugano, Switzerland, and Tokyo, Japan, [...]
Shire plc : Rule 2.9 Announcement
16/04/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 16 April 2018 [...]
Herantis Pharma announces positive interim data from Lymfactin study in secondary lymphedema
16/04/2018
Herantis Pharma announces positive interim data from Lymfactin study in secondary lymphedema Herantis Pharma Plc Company release 16 Apr 2018 at 9:00 am Herantis Pharma Plc ("Herantis") announced today positive results [...]
Lysogene Reports First Quarter Financial Results and Provides Business Update
16/04/2018
Extended CNS pipeline with a collaboration agreement for the development of an AAV-based gene therapy for Fragile X syndrome, the most common single gene cause of autism, a condition of high unmet medical need. [...]
Novartis announces new analysis demonstrating Entresto helped preserve kidney function in patients with chronic heart failure, especially those with diabetes
16/04/2018
Heart failure (HF) patients with reduced ejection fraction treated with Entresto experienced significantly less reduction in kidney function compared to patients treated with standard of care ACE inhibitor enalapril[1] [...]
Telix Pharmaceuticals, INSERM and ARRONAX Enter into Translational Research Partnership
16/04/2018
MELBOURNE, Australia and NANTES, France, April 16, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of [...]
NewLink Genetics Announces Initial Phase 1 Data with Indoximod Plus Radiation and Chemotherapy for Pediatric Patients with Diffuse Intrinsic Pontine Glioma (DIPG) Presented During AACR Plenary
15/04/2018
Early data indicate indoximod has clinical activity when used in combination therapies beyond PD-1 inhibition AMES, Iowa, April 15, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK ), today reported [...]
Thousands of People with Epilepsy and their Loved Ones Participate in the 12th Annual National Walk for Epilepsy on the National Mall
14/04/2018
Contributions Fund Research, Programs and Services for 3.4 Million People in the U.S. Living with Seizures WASHINGTON, April 14, 2018 (GLOBE NEWSWIRE) -- The Epilepsy Foundation is hosting its 12 th Annual National Walk [...]
Albireo Reports Data on Pharmacodynamic Marker for A4250 in Children with Cholestatic Liver Disease at The International Liver Congress™ 2018
14/04/2018
— Correlation observed between reduction in serum bile acids and autotaxin with A4250 — — Autotaxin has potential to be important biomarker of cholestatic pruritus — BOSTON, April 14, 2018 (GLOBE NEWSWIRE) -- Albireo [...]
Bradmer Pharmaceuticals, Galaxy Digital and First Coin Announce Update
13/04/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES. TORONTO, April 13, 2018 (GLOBE NEWSWIRE) -- Bradmer Pharmaceuticals Inc. (“ Bradmer ”) (TSX VENTURE:BMR.H), Galaxy Digital LP (“ [...]
Paratek Appoints Rolf K. Hoffman to Company’s Board of Directors
13/04/2018
-- Led U.S. and International Commercial Operations at Amgen Inc.-- BOSTON, April 13, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK ), a biopharmaceutical company focused on the development and [...]
Avivagen Announces the Issuance of Stock Options
13/04/2018
OTTAWA, April 13, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, [...]
Fluidigm Introduces High-Parameter Maxpar Immune Monitoring Panel for Translational and Clinical Research
13/04/2018
Providing the industry’s first commercially available high-parameter immune monitoring solution for deep profiling of PBMC, Fluidigm brings proven mass cytometry together with innovative third-party data analysis SOUTH [...]

Pages